Do Superantigens Play a Role in Lymphoproliferation?

References

• Festenstein H. Immunogenetic and biological aspects of an in vitro lymphocyte allo-transformation (MLR) in the mouse. Transplant Rev. 1973; 15: 62–88
   PubMed Web of Science ®Google Scholar
• Kappler J.W., Staerz U.D., White J., Marrack P.C. Self-tolerance eliminates T cells specific for Mis-modified products of the major histocompatibility complex. Nature 1988; 332: 35–40
   PubMed Web of Science ®Google Scholar
• MacDonald H.R., Schneider R., Lees R.L., Howe R.K., Acha-Orbea H., Festenstein H., Zinkernagel R.M., Hengartner H. T-cell receptor Vβ use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature 1988; 332: 40–45
   PubMed Web of Science ®Google Scholar
• Janeway C.A., Yagi J., Conrad P.J., Katz M.E., Jones B., Vroegop S., Buxser S. T-cell responses to Mis and to bacterial proteins that mimic its behavior. Immunol. Rev. 1989; 107: 61–88
   PubMed Web of Science ®Google Scholar
• White J., Herman A., Pullen A.M., Kubo R., Kappler J.W., Marrack P. The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989; 56: 27–35
   PubMed Web of Science ®Google Scholar
• Janeway C.A. Mls: makes a little sense. Nature 1991; 349: 459–461
   PubMed Web of Science ®Google Scholar
• Conrad B., Weidmann E., Trucco G., Rudert W.A., Behboo R., Ricordi C., Rodriquez-Rilo H., Finegold D., Trucco M. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994; 371: 351–355
   PubMed Web of Science ®Google Scholar
• Kotzin B.L., Leung D.M., Kappler J., Marrack P. Superantigens and their potential role in human disease. Adv. Immun. 1993; 54: 99–166
   PubMed Web of Science ®Google Scholar
• Germain R.M., Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. A. Rev. Immun. 1993; 11: 403–450
   PubMed Web of Science ®Google Scholar
• Matsumura M., Fremont D.H., Peterson P.A., Wilson I.A. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 1992; 257: 927–934
   PubMed Web of Science ®Google Scholar
• Brown J.H., Jardetzky T.S., Gorga J.C., Stern L.J., Urban R.G., Strominger J.L., Wiley D.C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993; 364: 33–39
   PubMed Web of Science ®Google Scholar
• Jorgensen J.L., Reay P.A., Enrich E.W., Davis M.M. Molecular components of T cell recognition. A. Rev. Immun. 1992; 10: 835–873
   PubMed Web of Science ®Google Scholar
• Dellabona P., Pecoud J., Kappler J., Marrack P., Benoist C., Mathis D. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 1990; 62: 1115–1121
   PubMed Web of Science ®Google Scholar
• Choi Y., Herman A., DiGiusto D., Wade T., Marrack P., Kappler J. Residues of the variable region of the T-cell receptor β-chain that interact with S. aureus toxin superantigens. Nature 1990; 346: 471–473
   PubMed Web of Science ®Google Scholar
• Cazenave P.A., Marche P.N., Jouvin-Marche E., Voegtle D., Bonhomme F., Bandeira A., Coutinho A. Vpi 7 gene polymorphism in wild-derived mouse strains: two amino acid substitutions in the VP17 region greatly alter T cell receptor specificity. Cell 1990; 63: 717–728
   PubMed Web of Science ®Google Scholar
• Pullen A.M., Wade T., Marrack P., Kappler J.W. Identification of the region of the T cell receptor P chain that interacts with the self superantigen Mls-R. Cell 1990; 61: 1365–1374
   PubMed Web of Science ®Google Scholar
• Pullen A.M., Bill J., Kubo R.T., Marrack P., Kappler J.W. Analysis of the sinteraction site for the self superantigen Mls-1a on T cell receptor vβ. J. Exp. Med. 1991; 173: 1183–1192
   PubMed Web of Science ®Google Scholar
• White J., Pullen A.M., Choi K., Marrack P., Kappler J.W. Antigen recognition properties of mutant vβ 3+ T cell receptors are consistent with an immunoglobulin-like structure of the receptor. J. Exp. Med. 1993; 177: 119–125
   PubMed Web of Science ®Google Scholar
• Jardetzky T.S., Brown J.H., Gorga J.C., Stern L.J., Urban R.G., Chi Y., Stauffacher C., Strominger J.L., Wiley D.C. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 1994; 368: 711–718
   PubMed Web of Science ®Google Scholar
• Sasso E.H., Silverman G.J., Mannik M. Human IgM molecules that bind staphylococcal protein A contain VHIII H chains. J. Immunol. 1989; 142: 2778–2783
   PubMed Web of Science ®Google Scholar
• Berberian L., Goodglick L., Kipps T.J., Braun J. Immunoglobulin VH3 gene products: Natural ligands for HIV gp120. Science 1993; 261: 1588–1591
   PubMed Web of Science ®Google Scholar
• Tsiagbe V.K., Thorbecke G.J. Paraproteins and primary lymphoma in SJL mice. I. Individuality of idiotypes on paraproteins. Cell. Immunol. 1990; 129: 494–502
   PubMed Web of Science ®Google Scholar
• Kaplan H.S. On the natural history of the murine leukemias: presidential address. Cancer Res. 1967; 27: 1325–1340
   PubMed Web of Science ®Google Scholar
• Sen-Majumdar A., Weissman I.L., et al. Radiation leukemia Virus-induced thymic lymphomas express a restricted repertoire of T-cell receptor Vp gene products. J. Virol 1994; 68: 1165–1172
   PubMed Web of Science ®Google Scholar
• Hugin A.W., Vacchio M.S., Morse H.C. A virus-encoded “superantigen” in a retrovirus-induced immunodeficiency syndrome of mice. Science 1991; 252: 424–427
   PubMed Web of Science ®Google Scholar
• Popovic M., Sarngadharan M.G., Read E., Gallo R.C. Detection, isolation and continuous production of cytopathic retro-viruses (HTLVIII) from patients with AIDS and pre-AIDS. Science 1984; 224: 497–500
   PubMed Web of Science ®Google Scholar
• Meyaard L., Otto S.A., Jonker R.R., Mijnster M.J., Keet R.P., Miedema F. Programmed death of T cells in HIV-1 infection. Science 1992; 257: 217–9
   PubMed Web of Science ®Google Scholar
• Imberti L., Sottini A., Bettinardi A., Puoti M., Primi D. Selective depletion in HIV infection of T cells that bear specific T cell receptor Vβ sequences. Science 1991; 254: 860–862
   PubMed Web of Science ®Google Scholar
• Soudeyns H., Routy J.-P., Sekaly R.-P. Comparative analysis of the T cell receptor Vβ repertoire in various lymphoid tissues from HIV-infected patients: Evidence for an HIV-associated superantigen. Leukemia 1994; 8(suppl. I)S95–97
   PubMedGoogle Scholar
• Pantaleo G., Demarest J.F., Soudeyns H., Graziosi C., Denis F., Adelsberger J.W., Borrow P., Saag M.S., Shaw G.M., Sekaly R.P., Fauci A.S. Major expansion of CD8+ T cells with a predominant Vp usage during the primary immune response to HIV. Nature 1994; 370: 463–467
   PubMed Web of Science ®Google Scholar
• Koup R.A., Ho D.D. Shutting down HIV. Nature 1994; 370: 416
   PubMed Web of Science ®Google Scholar
• Berberian L., Valles-Ayoub Y., Sun N., Martinez-Maza O., Braun J. A VHclonal deficit in human immunodeficiency virus positive individuals reflects a B-cell maturation arrest. Blood 1991; 78: 175–179
   PubMed Web of Science ®Google Scholar
• Amariglio N., Vonvover A., Hakim I., Neumann Y., Mark Z., Brok-Simoni F., Ben-Bassat I., Rechavi G. Immunoglobulin VH3-positive AIDS-related Burkitt's lymphoma: a possible role for the HIV gp 120 superantigen. Ada. Haematoi 1994; 91: 103–105
   PubMed Web of Science ®Google Scholar
• Riboldi P., Gaidano G., Schettino E.W., Steger T.G., Knowles D.M., Dalla-Favera R., Casali P. Two Acquired Immunodeficiency Syndrome-associated Burkitt's Lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH 4–21 segments. Blood 1994; 2952–2961
   PubMed Web of Science ®Google Scholar
• Ng V.L., Hurt M.H., Fein C.L., Khayam-Bashi F., Marsh J., Nunes W.M., McPhaul L.W., Feigal E., Nelson P., Herndier B.G., Shiramizu B., Reyes G.R., Fry K.E., McGrath M.S. IgMs produced by two acquired immune deficiency syndrome lymphoma cell lines: Ig binding specificity and VH-gene putative somatic mutation analysis. Blood 1994; 83: 1067–1078
   PubMed Web of Science ®Google Scholar
• Hurt M., Herndier B., Ng V., McGrath M.S. Inter-VH-gene family shared idiotype on acquired immunodeficiency syndrome-associated lymphomas. Blood 1994; M84: 986–987
   Google Scholar
• Konrad R.J., Kricka L.J., Goodman D.B., Goldman J., Silberstein L.E. Brief report: myeloma-associated para-protein directed against the HIV-1 p24 antigen in an HIV-1 seropos-itive patient. N. Engl. J. Med. 1993; 328: 1817–1819
   PubMed Web of Science ®Google Scholar
• Mann D.L., DeSantis P., Mark G., Pfeifer A., Newman M., Gibbs N., Popovic M., Sarngadharan M.G., Gallo R.C., Clark J., Blattner W. HTLV-I-associated B-cell CLL: Indirect role for retrovirus in leukemogenesis. Science 1987; 236: 1103–1106
   PubMed Web of Science ®Google Scholar
• Smith T.J., Terada N., Robinson C.C., Gelfand E.W. Acute infectious mononucleosis stimulates the selective expression/expansion of V beta 6.1–3 and V beta 7 T cells. Blood 1993; 81: 1521–1526
   PubMed Web of Science ®Google Scholar
• Isaacson P.G., Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 1987; 11: 445–462
   PubMed Web of Science ®Google Scholar
• Wotherspoon A.C., Doglioni C., Diss T.C., Pan L., Moschini A., de Boni M., Isaacson P.G. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575–577
   PubMed Web of Science ®Google Scholar
• Hussel T., Isaacson P.G., Crabtree J.E., Spencer J. the response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571–574
   PubMed Web of Science ®Google Scholar
• Weissman I.L., Baird S. In Neoplastic Transformation: Mechanisms and consequences, H. Koprowski. Dahlem Komferenzen, Berlin 1977; 135
   Google Scholar
• McGrath M.S., Weissman I.L. In Differentiation of Normal and Neoplastic Hematopoietic Cells, B. Clarkson, P.A. Marks, J.E. Till. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 1978; 577
   Google Scholar